ANNE CLARK: Open Payments
NPI 1023033560 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 99 payments from 18 companies in 2025. Trend: 2023 $1,002 · 2024 $1,292 · 2025 $1,391
Food & beverage: $1,391
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $300 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $152 |
| Collegium Pharmaceutical, Inc. | 9 | $140 |
| Axsome Therapeutics, Inc. | 6 | $109 |
| E.R. Squibb & Sons, L.L.C. | 6 | $108 |
| Otsuka America Pharmaceutical, Inc. | 6 | $98 |
| Tris Pharma Inc | 6 | $97 |
| Vanda Pharmaceuticals Inc. | 4 | $70 |
| Lundbeck LLC | 4 | $66 |
| Supernus Pharmaceuticals, Inc. | 2 | $49 |
Products named: VRAYLAR, REXULTI, CAPLYTA, Jornay PM, Auvelity, COBENFY, Dyanavel XR, HETLIOZ.
Industry payments across KS — which companies pay providers there.
